Expression of Serum hs-CRP and Lp-PLA2 in Arrhythmia Patients and its Significance
CONG Xiu-feng
Department of Clinical Oncology, Shengjing Hospital of China Medical University, Liaoning Province Shenyang 110024, China
摘要：Objective: The purpose of this study is to examine the expression ofserum high-sensitivity C-reactive protein (hs-CRP) and lipoprotein-associated phospholipase A2 (Lp-PLA2) in patients with arrhythmia and its significance. Methods:We selected 136 arrhythmia patients (observation group) who were treated at our hospital from February 2016 to March 2018. Among these patients, 50 had premature ventricular contractions, 42 had atrial fibrillation, 24 had atrial flutter, and 20 had ventricular tachycardia. Simultaneously, we selected 120 healthy volunteers as the control group. We measured serum levels of hs-CRP and Lp-PLA2 in these subjects. Results: The levels of Lp-PLA2 and hs-CRP of the observation group were 210.06 ±30.46 pg/mL and 13.54±3.16, respectively, which were significantly higher than those of the control group (P<0.05). The serum levels of Lp-PLA2 and hs-CRP of patients with atrial flutter were 260.87 ±32.24 and 19.84 ±5.10 pg/mL, respectively, which were significantly higher than those of patients with premature ventricular contractions, atrial fibrillation, and ventricular tachycardia (P<0.05). Serum levels of Lp-PLA2 and hs-CRP were posi-tively correlated (r=0.413, P<0.05). Conclusion:Serum levels of hs-CRP and Lp-PLA2 in arrhythmia patients were significantly elevated and showed some association with the type of arrhythmia.
机标关键词：
分类号：R541.4(心脏、血管（循环系）疾病)
论文发表日期：2019-06-30
在线出版日期：2025-08-15（本平台首次上网日期，不代表文献的发表时间）
页数：6( 66-71 )
英文信息